UK markets closed

Citius Pharmaceuticals, Inc. (CTXR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.7050-0.0020 (-0.28%)
At close: 04:00PM EDT
0.7100 +0.00 (+0.71%)
After hours: 06:52PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
30/09/2023
30/09/2022
30/09/2021
30/09/2020
Cash flows from operating activities
Net income
-38,180
-32,543
-33,641
-23,054
-17,548
Depreciation & amortisation
198.137
194.316
179.677
164.868
152.364
Deferred income taxes
576
576
576
0
-
Stock-based compensation
8,474
6,617
3,906
1,455
803.261
Change in working capital
-1,617
-4,006
239.555
-2,717
-866.968
Accounts payable
1,110
1,762
-111.717
-579.14
-857.307
Other working capital
-30,371
-29,060
-28,361
-64,257
-16,932
Other non-cash items
500.117
102
378.204
68
528.77
Net cash provided by operating activities
-30,371
-29,060
-28,361
-24,250
-16,931
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-
-40,007
-1.831
Net cash used for investing activities
-
-
0
-40,007
-1.831
Cash flows from financing activities
Debt repayment
-
-
0
-172.97
0
Common stock issued
-
13,798
0
89,431
15,577
Net cash used provided by (used for) financing activities
-
13,829
0
120,471
22,898
Net change in cash
-16,542
-15,231
-28,361
56,213
5,966
Cash at beginning of period
36,887
41,712
70,073
13,860
7,894
Cash at end of period
20,346
26,481
41,712
70,073
13,860
Free cash flow
Operating cash flow
-30,371
-29,060
-28,361
-24,250
-16,931
Capital expenditure
-
-
-
-40,007
-1.831
Free cash flow
-30,371
-29,060
-28,361
-64,257
-16,932